BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//European Brain Council (EBC) - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.braincouncil.eu
X-WR-CALDESC:Events for European Brain Council (EBC)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240406
DTEND;VALUE=DATE:20240410
DTSTAMP:20260416T004249
CREATED:20231128T133559Z
LAST-MODIFIED:20240405T072445Z
UID:50556-1712361600-1712707199@www.braincouncil.eu
SUMMARY:32nd European Congress of Psychiatry
DESCRIPTION:The 32nd European Congress of Psychiatry will take place 6-9 April 2024 in Budapest (Hungary). \nAs a global and multi-cultural hub\, Budapest is at the crossroads between East and West\, and as such\, excellently placed for a bridging role in Europe. Indeed\, in these complex geopolitical times\, the importance of joining together\, crossing borders\, and overcoming differences is more crucial than ever. \nThe Congress will take place under the motto ‘Mental Health: Open and Inclusive!’. It highlights three core aspects of modern psychiatry: \n\nMental health as a broad dimension from mental health prevention and resilience building to the treatment of specific disorders.\nOpen refers not only to our fundamental human rights but also to open mindedness and curiosity for novel approaches and ideas.\nInclusive implies welcoming and respecting differences between people.\n\nEBC looks forward to being part of the exhibition area and holding the following session: \n\nAssessing the Value of Mental Health Treatments for Youth in Europe\, 7 April 2024\, 10:00-11:30 (symposium)\nRethinking Schizophrenia: Beyond the Voices\, 7 April 2024\, 08:00-17:00 (e-poster viewing)\n\nFind out more!For privacy reasons YouTube needs your permission to be loaded. For more details\, please see our Privacy Policy.I Accept
URL:https://www.braincouncil.eu/event/32nd-european-congress-of-psychiatry/
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2023/11/EPA-2024-Congress-Social-Toolkit-Join-me-1600x900px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240407T080000
DTEND;TZID=Europe/Paris:20240407T170000
DTSTAMP:20260416T004249
CREATED:20240207T092653Z
LAST-MODIFIED:20240405T072509Z
UID:52303-1712476800-1712509200@www.braincouncil.eu
SUMMARY:Rethinking Schizophrenia: Beyond the Voices | European Congress of Psychiatry
DESCRIPTION:EBC is pleased to have an e-poster viewing “Rethinking Schizophrenia: Beyond the Voices” at the upcoming European Congress of Psychiatry\, set to take place on 6-9 April 2024 in Budapest (Hungary). The e-poster will be displayed at 08:00-17:00 on 7 April 2024 in the e-poster area. \nThe e-poster will feature the Rethinking schizophrenia project\, coordinated by EBC. Rethinking Schizophrenia is a research-driven project offering tangible policy changes to improve the lives of people living with schizophrenia across Europe. It challenges the status quo and refreshes the European policy debate on people living with schizophrenia and encourages multi-stakeholder-driven policy. The project falls under #BeyondTheVoices campaign. \nPéter KériPresident\, GAMIAN-Europe Peer-support professional with background in education\, public relations\, and mental health advocacy. Graduating as a teacher\, he earned his first diploma. His journey continued as he pursued a second diploma in PR at the Metropolitan University. \nCurrently serving as the head of international relations\, grants\, and innovations at the Awakening Foundation in Hungary\, Kéri Péter plays a pivotal role in fostering global connections and driving innovative initiatives. Kéri Péter holds the position of President at GAMIAN-Europe\, the continent’s leading organization dedicated to supporting patients struggling with mental health challenges. He further contributes to the field as a Board Member of the European Psychiatric Association. Since 2013\, Kéri Péter has been at the forefront of exploring innovative approaches that complement traditional research methodologies. \nHis commitment to enhancing patient care is evident through his role as the project leader of the Expert by Experience pilot project initiated by the foundation. His focus revolves around empowering patients within the social and healthcare systems\, advocating for their involvement in decision-making processes. He is dedicated to identifying both facilitators and barriers related to patient participation and effectively communicating these findings to decision-makers on both national and international fronts. \nBeyond his organizational roles\, Kéri Péter is a speaker\, and contributor to scientific publications in the field of mental health. His passion for driving positive change is reflected in his numerous international presentations\, research endeavors\, and contributions to scientific discourse.
URL:https://www.braincouncil.eu/event/beyond-the-voices-of-schizophrenia-european-congress-of-psychiatry/
LOCATION:Budapest\, Hungary
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240407T100000
DTEND;TZID=UTC:20240407T113000
DTSTAMP:20260416T004249
CREATED:20231201T124403Z
LAST-MODIFIED:20240327T090721Z
UID:50642-1712484000-1712489400@www.braincouncil.eu
SUMMARY:Assessing the Value of Mental Health Treatments for Youth in Europe | European Congress of Psychiatry
DESCRIPTION:EBC is pleased to host a symposium on ‘Assessing the Value of Mental Health Treatments for Youth in Europe’\, set to take place on 7 April 2024 at 10:00-11:30 at the 32nd European Congress of Psychiatry. \nWhile substantially diverse across healthcare segments and ill-health conditions\, excess healthcare costs associated with the increased risks of physical comorbidities linked to mental health disorders have been found to be between 37% to 110%\, calling for more tailored policy considerations towards integrated care options. Furthermore\, the economic value of life years lost due to morbidity and mortality linked to mental health disorders exceeds their cost impact: recently\, this was valued as between 6% and 7.7% of GDP in Europe\, suggesting potentially large returns on investment from improved prevention\, detection\, and treatment of mental health problems. \nEBC Value of Treatment (VOT) Study ResultsThe European Psychiatry\n \nEffective and cost-effective early detection and interventions exist\, however there are numerous unmet needs along the mental health care pathways. Navigating the mental health services system is often complex for patients and families due to fragmented or disrupted services (in-patient and outpatient care) and discontinuity of care (transition between child and adult mental health services\, for example). Policies and programmes to prevent and mitigate the negative impacts on schooling\, employment\, families and risky behaviors are also paramount. Nevertheless\, spill-over effects to other economic sectors (work\, education\, legal system\, informal care) are usually neglected in economic burden and value assessments. Current value estimates usually also remain limited in terms of comprehensive outcome assessment for patients and families\, and comprehensive and comparable societal cost impact assessment due to the lack of relevant data. \nThere is a clear need to look at value-based healthcare as the desired solution or path forward in improving health systems. Achieving high value for patients must become the overarching goal of health care delivery\, with value defined as the health outcomes achieved per money spent. The approach towards more comprehensive mental health care models critically intertwines wider patient and societal outcomes with efficient spending of resources. Reinforcing this should lead to both better care for patients and a more sustainable framework for payers in Europe. Speakers of the session and experts involved in the Value of Treatment project\, coordinated by the European Brain Council\, will focus on early detection and continuity of care for persons living with selected mental disorders. The research project – which combines care pathways analysis and economic analyses – included three case studies related to anorexia nervosa (AN)\, autism spectrum disorder (ASD) and major depressive disorder (MDD). It aimed to identify treatment gaps\, assess the potential outcomes and costs of optimised care\, and provide policy recommendations. \nSEE THE PROGRAMMEChair & Co-chairJudit Balazs\nChair of the Child Psychiatry Section\, European Psychiatric Association \nDanuta Wasserman\nPresident\, World Psychiatric Association \nSpeakersCelso Arango\nChair of the Child and Adolescent Department of Psychiatry\, Hospital General Universitario Gregorio Marañón \nAllan H Young\nProfessor of Psychiatry\, King’s College London \nDavid McDaid\nAssociate Professorial Research Fellow in Health Policy and Health Economics\, London School of Economics and Political Science \nJudit Simon\nProfessor of Health Economics\, Medical University of Vienna \nBiographiesJudit Balazs\nShe is Professor Eotvos Lorand University\, Budapest\, Hungary\, and New University College\, Oslo\, Norway; Doctor of Sciences of the Hungarian Academy of Sciences; head and tutor of the Developmental and Clinical Child Psychology Program at the Doctoral Schools of Eotvos Lorand University\, Budapest; tutor of the Semmelweis University\, Budapest. \nHer main interests are adolescent suicide prevention\, neurodevelopmental disorders and subthreshold mental disorders\, migration-acculturation-mental health\, and quality of life. She is the first author of several peer-reviewed papers and the editor of a textbook on Child and Adolescent Psychiatry\, published both in Hungarian and English. She was the Hungarian partner Principal Investigator of three EU-sponsored collaborative projects and several local projects on youth mental health. \nShe was the president of the Hungarian Psychiatric Association and chair of the Suicide Network of the European College of Neuropsychopharmacology. She is the chair of the Child Psychiatry Section of the European Psychiatric Association. \nDanuta Wasserman\nDanuta Wasserman M.D.\, Ph.D. is the President (2023-2026) of the World Psychiatric Association (WPA)\, comprising 147 psychiatric associations and 250\,000 psychiatrists from 123 countries\, and a University Professor of Psychiatry and Suicidology at Karolinska Institutet (KI) in Stockholm\, Sweden. Professor Wasserman is the Founder of the National Centre for Suicide Research and Prevention of Mental Ill-Health (NASP) at KI\, and she is the Director of the WHO Collaborating Centre for Research\, Methods Development\, and Training in Suicide Prevention\, a collaboration with the WHO Global office in Geneva.  She is also the former President of both the European Psychiatric Association (EPA)\, composed of 44 National Psychiatric Association Members from 40 European countries\, and the International Academy of Suicide Research (IASR). Professor Wasserman’s scientific work in suicide prevention is globally recognized\, and she has recently expanded her focus to include wellbeing and mental health promotion in the general population\, psychiatric patients\, and psychiatric staff through advocating for healthy lifestyle choices such as physical activity\, nutrition\, and good sleep habits. \nCelso Arango\nProfessor Celso Arango is currently Chair of the Child and Adolescent Department of Psychiatry at Hospital General Universitario Gregorio Marañón\, Complutense University in Madrid\, Spain\, as well as Director of the Gregorio Marañón Psychiatric and Mental Health Institute\, Professor of Psychiatry at the Maryland Psychiatric Research Center of the University of Maryland in Baltimore\, Adjunct Professor of Psychiatry at UCSF in San Francisco\, Visiting Professor of Psychiatry at Kings College London\, and Tenured Full Professor at Complutense University in Madrid. \nProfessor Arango completed his medical studies in 1992 at both the University of Oviedo in Spain and Manchester University in the UK. He later received his PhD in Psychiatry from Complutense University of Madrid in 1997. Currently\, Professor Arango’s major research interests include the neurobiology of early-onset and first-episode psychoses and neurodevelopmental psychopharmacology. He has received more than 73 awards for his work. \nAllan H Young\nProfessor Allan Young is Chair of Mood Disorders and Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry\, Psychology and Neuroscience at King’s College London\, where he is also Head of School for Academic Psychiatry. The School of Academic Psychiatry is second in the world rankings for Psychiatry. He is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust\, where he is also Consultant Psychiatrist and Head of the Affective Disorders Service. \nProfessor Young’s research interests focus on the cause and treatments for severe psychiatric illnesses\, particularly mood disorders. He has received research grants from several funding agencies and has over 700 peer-reviewed publications\, including several books about psychopharmacology and affective disorders. \nDavid McDaid\nDavid McDaid is Associate Professorial Research Fellow in Health Policy and Health Economics within the Care Policy and Evaluation Centre\, Department of Health Policy at the London School of Economics and Political Science. The primary focus of David‘s work is on using economic arguments to support investment in mental health and wellbeing promotion\, self-harm\, suicide and mental illness prevention within and beyond the health sector and across the life course. He has published extensively on these topics and has provided advice to a number of governments and ministries of health\, as well as international organisations including European Commission\, OECD\, WHO and UNICEF. \nJudit Simon\nJudit Simon is Professor of Health Economics\, Head of the Department of Health Economics\, Deputy Head of the Center for Public Health and Coordinator of the Public Health Doctoral programme at the Medical University of Vienna. She is Visiting Professor at the University of Oxford and Corvinus University Budapest. \nHer main expert areas include applied and methodological health economic evaluation research alongside clinical studies/guidelines/HTAs\, evidence synthesis and health services and systems research. She has been PI/co-I on 23 grants with over 40 million Euros funding (CDL\, EC\, ECNP\, FWF\, LBG\, NIHR\, WHO\, WWTF) in the fields of mental health\, public health\, nutrition\, cancer and palliative care economics. Most recently\, she has led European research on improving (mental) health economic evaluation methods (PECUNIA)\, the physical comorbidity costs of mental disorders\, the cost-effectiveness of palliative/end-of-life care (iLIVE) and the value of family-intervention for adolescent mental health promotion in Eastern Europe (FLOURISH)\, as well as acted as advisor to the EBC Value of Treatment project. She has over 170 publications\, and is senior editor at BMJ Mental Health\, BJPsych Open and Bipolar Disorders.
URL:https://www.braincouncil.eu/event/symposium-epa2024/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240411T083000
DTEND;TZID=UTC:20240412T170000
DTSTAMP:20260416T004249
CREATED:20240312T103155Z
LAST-MODIFIED:20240313T142222Z
UID:53369-1712824200-1712941200@www.braincouncil.eu
SUMMARY:Mind Your Body: Symposium on immuno-psychiatry
DESCRIPTION:Research theme of the meeting\nIn medical sciences\, we still have the tendency to view the mind dissociated/separated from the body. This meeting calls for moving beyond the dualism to understand how immunological and metabolic processes in the body affect brain and mind\, particularly in psychiatric disorders. We will discuss the interplay between immunological and metabolic processes as a central feature of the mechanisms by which the periphery and brain communicate and can contribute to psychiatric symptoms and the observed multimorbidity between psychiatric and non-mental diseases. \nIntended outcome of the meeting\nThe intended outcome of the meeting is twofold. First\, this meeting is set-up to combine expertise and share knowledge across the relevant disciplines. By integrating multidisciplinary views and perspectives on the topic\, we will identify current knowledge gaps and develop a research agenda together that can address the relevant scientific problems in question. Specifically\, we will formulate hypotheses on the most likely biological mechanisms underlying multimorbidity between psychiatric and somatic conditions\, and we will suggest appropriate methodological approaches. Second\, this meeting will manifest new collaborations and capitalize on existing collaborations. \nAbstracts can be submitted until the 28th of March. Please send an email with your abstract attached as a Word document to barbara.sakic@radboudumc.nl. You will be notified by the 2nd of April regarding approval to give a presentation. \nAbstracts should not exceed 250 words (excluding title\, author(s)\, and affiliation(s)\, and they should have a structured lay-out as follows: background\, methods\, results\, conclusions. \nRegister here
URL:https://www.braincouncil.eu/event/mind-your-body-symposium-on-immuno-psychiatry/
LOCATION:Conference center Soeterbeeck\, The Netherlands
ATTACH;FMTTYPE=application/pdf:https://www.braincouncil.eu/wp-content/uploads/2024/03/Mind-Your-Body-symposium_flyer_2024.pdf
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240416T170000
DTEND;TZID=Europe/Paris:20240416T190000
DTSTAMP:20260416T004249
CREATED:20240318T110632Z
LAST-MODIFIED:20240325T075429Z
UID:53614-1713286800-1713294000@www.braincouncil.eu
SUMMARY:Exclusive Movie Premiere: Unconditional
DESCRIPTION:UNCONDITIONAL is an award-winning film about caregiving and mental health. An Oscars-qualified film honoured at the White House\, United Nations & U.S. Congress\, marks its International Premiere this April at the European Parliament\, hosted by Jan Zahradil\, Member of the European Parliament.\n\nAs part of the programme\, EBC Executive Director\, Frédéric Destrebecq will give the opening remarks.\n\n\n\n\nComplimentary ticket includes a screening\, discussion on caregiving and mental health\, and cocktail reception with award-winning director RICHARD LUI (NBC News\, xCNN Worldwide anchor). Tickets are distributed on a first-come\, first-serve basis.\n\n\nAbout the filmSeven years in the making\, a first of its kind film from award-winning filmmaker Richard Lui\, on the topic that affects 100 million Americans – mental health. Watch three families bravely turn the corner\, showing us the power of relearning how to love. \nThomas Family\nKate Hendricks Thomas\, a mental health expert and Marine Corps veteran who has given three TED talks and written three books\, now faces her biggest challenge — preparing herself\, her husband Shane\, and her 5-year old son for her terminal cancer diagnosis. In a tough irony\, she is practicing what she preached so well.\nBushatz Family\nAs memories of Afghanistan linger\, Luke Bushatz’s young son’s try to understand why their hero sometimes loses his temper. All the while\, his wife Amy shares the struggles they both face to get past go.\nLui Family\nStephen Lui\, who spent his career caring for senior citizens as a social worker and pastor\, now battles his eighth year of Alzheimers. And like Kate\, boldly had to practice what he preached. His wife and children\, by his side\, face their own struggles to do the right thing.\nREAD MORE ABOUT THE MOVIERegister here
URL:https://www.braincouncil.eu/event/exclusive-movie-premiere-unconditional/
LOCATION:European Parliament\, Rue Wiertz 60\, Brussels\, 1047\, Belgium
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2024/03/EU-Event-Invitation-3.17.24-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240419
DTEND;VALUE=DATE:20240421
DTSTAMP:20260416T004249
CREATED:20240325T094916Z
LAST-MODIFIED:20240326T140324Z
UID:53708-1713484800-1713657599@www.braincouncil.eu
SUMMARY:EMSP Annual Conference 2024
DESCRIPTION:Multiple Sclerosis – toward sustainable and healthier systems in EuropeEMSP Annual Conference 2024 with the theme of Multiple Sclerosis – toward sustainable and healthier systems in Europe\, will take place between 19-20 April 2024 in Thon Hotel EU (Rue de la Loi 75) in Brussels\, Belgium. \nAs part of a programme\, Frédéric Destrebecq\, EBC Executive Director will hold a session on 19 April at 15:45 on the topic “Commitment to MS and other related rare conditions cure: Advancing research in Europe”. \nHeld as an in-person event co-hosted by the Belgian Society\, the conference will offer the latest Multiple Sclerosis developments\, expert insights\, and networking with the community. \nRead more about the eventRegister here
URL:https://www.braincouncil.eu/event/emsp-annual-conference-2024/
LOCATION:Brussels\, Belgium
ATTACH;FMTTYPE=image/webp:https://www.braincouncil.eu/wp-content/uploads/2024/03/734ebf865ab84e378eba86c63f503337_511529c11819d466f9c80578c0a69287.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240424
DTEND;VALUE=DATE:20240427
DTSTAMP:20260416T004249
CREATED:20240103T135316Z
LAST-MODIFIED:20240313T123741Z
UID:51279-1713916800-1714175999@www.braincouncil.eu
SUMMARY:36th Global Conference of Alzheimer’s Disease International
DESCRIPTION:The 36th Global Conference of Alzheimer’s Disease International will take place in Kraków\, Poland from 24-26 April 2024\, with ADI member Polskie Stowarzyszenie Pomocy Osobom z Chorobą Alzheimera (Polish Alzheimer’s Association). \nComing together under the conference theme of ‘Dementia: Insights. Innovations. Inspirations.’\, the conference will bring together experts from across the world to share information on achievements\, innovations and best practices in dementia research\, care and policy\, while continuing to address and challenge the perceptions around dementia. \nThe conference will follow on from ADI 2022 and be offered in hybrid format\, combining in-person and virtual elements for an educational and interactive experience for delegates. \nThe conference programme will be structured around the 7 action areas of the World Health Organization (WHO)’s Global Action Plan on dementia\, which centre around policy\, awareness\, prevention and diagnosis\, research\, care and treatment of dementia. \nEBC is pleased to be part of this year’s conference and hold the following presentations highlighting the Rethinking Alzheimer’s disease project\, calling for change in Alzheimer ‘s care: \n\nRethinking Alzheimer’s disease: Cross-roads in the earlier detection and diagnosis of Alzheimer’s (poster presentation)\, 24-26 April 2024\nRethinking Alzheimer’s disease: Scaling up health systems’ readiness\, 26 April 2024\, 13:30-15:00
URL:https://www.braincouncil.eu/event/36th-global-conference-of-alzheimers-disease-international/
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2024/01/miedzynarodowa-konferencja-choroby-alzheimera-adi-krakow-2024.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240424
DTEND;VALUE=DATE:20240427
DTSTAMP:20260416T004249
CREATED:20240207T093741Z
LAST-MODIFIED:20240318T133124Z
UID:52305-1713916800-1714175999@www.braincouncil.eu
SUMMARY:Rethinking Alzheimer’s disease: Cross-roads in the earlier detection and diagnosis of Alzheimer's | 36th Global Conference of Alzheimer's Disease International
DESCRIPTION:EBC is pleased to hold a poster presentation “Rethinking Alzheimer’s disease: Cross-roads in the earlier detection and diagnosis of Alzheimer’s” at the upcoming 36th Global Conference of Alzheimer’s Disease International. The Conference will take place from 24-26 April 2024 in Krakow (Poland). The poster will be presented by Charlotte Teunissen\, Professor in Neurochemistry\, Chair of the Neurochemistry lab (Amsterdam UMC) and one of the experts involved in the Rethinking Alzheimer’s disease project. \nAlzheimer’s disease (AD)\, the most common form of dementia\, is a progressive and debilitating neurodegenerative condition which robs people of their memory\, their independence\, their relationships and\, ultimately\, their lives. It affects close to 7 million people in the European Union (EU) alone. \nThe detection and diagnosis of AD relies on a system that remains focused on the late stage of the disease\, despite a better understanding of the disease progression. Clinical practice and healthcare systems’ readiness to detect\, diagnose and treat the disease effectively are still lagging. The use of biomarkers (cerebrospinal fluid tests (CSF) and positron emission tomography scans (PET))\, which are central to a diagnostic assessment for people with AD symptoms\, as well as relevant diagnostic facilities are under-utilised. PET imaging is expensive and of limited availability\, and CSF sampling may be considered invasive. \nThe European Brain Council’s ‘Rethinking Alzheimer’s disease: Detection and diagnosis’ White Paper has looked at the barriers to early diagnosis and how the healthcare systems infrastructure for detection and diagnosis of AD need to be transformed in order for people with AD to benefit from innovative solutions once they become approved for use. The Rethinking Schizophrenia project falls under the Rethinking the management of brain disorders series\, research-driven projects offering policy recommendations to make tangible changes with the aim to improve the lives of people living with brain disorders\, neurological and mental alike\, across Europe. More details about the outcomes of the Rethinking Alzheimer’s disease project can be found in this article. \nSpeakerCharlotte Teunissen  \nProfessor in Neurochemistry\, Chair of the Neurochemistry lab\, Amsterdam UMC.  \nCharlotte Teunissen's drive is to improve care of patients with neurological diseases by developing body fluid biomarkers for diagnosis\, stratification\, prognosis and monitoring treatment responses. Studies of her research group span the entire spectrum of biomarker development\, starting with biomarker identification\, often by –omics methods\, followed by biomarker assay development and analytical validation\, and lastly\, extensive clinical validation and implementation of novel biomarkers in clinical practice.   \nShe has extensive expertise with assay development on state of the art technologies\, such as mass spectrometry and antibody-based arrays for biomarker discovery\, ultrasensitive immunoassays\, and in in implementation of vitro diagnostic technologies for clinical routine lab analysis. She is responsible for the large well-characterised biobank of the Amsterdam Dementia cohort\, containing >6000 paired CSF and serum samples of individuals visiting the memory clinical of the Alzheimer Center Amsterdam  (a.o. controls\, patients with Alzheimer\, Frontotemporal\, Lewy Bodies).To ensure the quality of the biosamples\, the group studies  pre-analytical effects\, which are key to implementation. Charlotte is leading several collaborative international biomarkernetworks\, such as the Society for Neurochemistry and routine CSF analysis and the Alzheimer Association-Global Biomarker Standardization and Blood Based Biomarkers and the Body fluid Biomarkers PIA\, \, and the recently founded Coral proteomics consortium. She is the coordinator of the Marie Curie MIRIADE project\, aiming to train 15 novel researchers into innovative strategies to develop dementia biomarkers (10 academic centers + 10 non-academic centers)\, and the JPND bPRIDE project\, that aims to develop targeted blood based biomarker panels for early differential diagnoses of specific dementias and is a collaborative project between 7 European and 1 Australian centers.  
URL:https://www.braincouncil.eu/event/rethinking-alzheimers-disease-cross-roads-in-the-earlier-detection-and-diagnosis-of-alzheimers/
LOCATION:Krakow\, Poland
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240425
DTEND;VALUE=DATE:20240428
DTSTAMP:20260416T004249
CREATED:20240118T075548Z
LAST-MODIFIED:20240314T150457Z
UID:51688-1714003200-1714262399@www.braincouncil.eu
SUMMARY:13th Neuronus Neuroscience Forum
DESCRIPTION:The Neuronus Neuroscience Forum\, set to take place on 25-27 April 2024\, serves as an international and interdisciplinary conference hosted at the renowned Jagiellonian University in Krakow\, Poland. Its primary aim is to establish a dynamic platform for researchers across different career stages\, facilitating the open exchange of ideas and experiences drawn from diverse corners of the globe. Attendees are provided with a unique opportunity to unveil their research findings\, often marking a significant milestone in their professional journeys. Complementing this\, the event organizes a range of career-enhancing workshops and networking events. The conference program comprehensively covers various facets of neuroscience\, shedding light on the latest research trends and serving as a source of inspiration for all scientists embarking on innovative projects. \nABOUT NEURONUS\nThe main goal of the conference is to provide an opportunity for researchers to share their latest findings\, knowledge and experience\, as well as to make valuable connections with scientists representing different fields of neuroscience. We will encounter reflections on the neurobiological basis of love and on the role of the visual cortex in blind people. We will also learn about the impact of a healthy lifestyle on intelligence or the ageing process. \nThe event programme includes four thematic blocks – Cognitive Neuroscience\, Biological Neuroscience\, Computational Neuroscience and Medical Neuroscience. The first of these presents psychophysiological research\, related to the processing of emotions or perception. The second block is the study of the basic mechanisms of neuroscience\, such as the basis of neurodegenerative diseases. The Computational block focuses on research in neuroinformatics\, such as the development of artificial neural networks. The last block presents issues of neurology and psychiatry and clinical cases of diseases of the nervous system. \nThe schedule includes oral presentations\, poster sessions and plenary lectures by experts in the fields of research on the functioning of the nervous system. This year the invitation was accepted by Quentin Huys (Max Planck Institute\, Germany)\, Sebastian Haesler (Katholieke Universiteit Leuven\, Belgium)\, Jim Haxby (Dartmouth College\, USA)\, Andrew Holmes (University of Newcastle\, USA)\, Gaia Novarino (Institute of Science and Technology\, Austria)\, Katharina Wulff (Umeå Universitet\, Sweden) and Phlippe Schyns (University of Glasgow\, Scotland). \nWHERE AND WHEN?\nThe conference will take place from 25th to 27th of April 2024 at the Auditorium Maximum of the Jagiellonian University. On the day before the conference (24th of April) there will be organized workshops for young scientists on scientific data analysis and career-building\, providing a unique opportunity to gain valuable experience and broaden your skills. \nFind out more!
URL:https://www.braincouncil.eu/event/13th-neuronus-neuroscience-forum/
LOCATION:Krakow\, Poland
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/01/poster_2024.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240426T133000
DTEND;TZID=UTC:20240426T150000
DTSTAMP:20260416T004249
CREATED:20240207T094137Z
LAST-MODIFIED:20240318T134058Z
UID:52307-1714138200-1714143600@www.braincouncil.eu
SUMMARY:Diagnosis\, diagnostic tools and cognitive assessments | 36th Global Conference of Alzheimer's Disease International
DESCRIPTION:EBC is pleased to be part of the session “Diagnosis\, diagnostic tools and cognitive assessments” at the upcoming 36th Global Conference of Alzheimer’s Disease International. The session will take place on 26 April 2024 at 13:30-15:00 in Krakow (Poland). Prof. Giovanni Frisoni will present “Rethinking Alzheimer’s disease: Scaling up health systems’ readiness” as one of the experts involved in the Rethinking Alzheimer’s disease project\, coordinated by EBC. \nAlzheimer’s disease (AD)\, the most common form of dementia\, is a progressive and debilitating neurodegenerative condition which robs people of their memory\, their independence\, their relationships and\, ultimately\, their lives. It affects close to 7 million people in the European Union (EU) alone. \nThe detection and diagnosis of AD relies on a system that remains focused on the late stage of the disease\, despite a better understanding of the disease progression. Clinical practice and healthcare systems’ readiness to detect\, diagnose and treat the disease effectively are still lagging. The use of biomarkers (cerebrospinal fluid tests (CSF) and positron emission tomography scans (PET))\, which are central to a diagnostic assessment for people with AD symptoms\, as well as relevant diagnostic facilities are under-utilised. PET imaging is expensive and of limited availability\, and CSF sampling may be considered invasive. \nThe European Brain Council’s ‘Rethinking Alzheimer’s disease: Detection and diagnosis’ White Paper has looked at the barriers to early diagnosis and how the healthcare systems infrastructure for detection and diagnosis of AD need to be transformed in order for people with AD to benefit from innovative solutions once they become approved for use. The Rethinking Schizophrenia project falls under the Rethinking the management of brain disorders series\, research-driven projects offering policy recommendations to make tangible changes with the aim to improve the lives of people living with brain disorders\, neurological and mental alike\, across Europe. More details about the outcomes of the Rethinking Alzheimer’s disease project can be found in this article. \nSpeakerGiovanni B Frisoni\, neurologist \nClinical neurologist\, Full Professor of Clinical Neuroscience at the University of Geneva\, Switzerland\, and Director of the Memory Clinic of the Geneva University Hospital. Former Scientific Director at the National Alzheimer’s Centre in Brescia\, Italy. Author of over 700 scientific papers listed in PubMed\, imaging editor for Neurobiology of Aging\, and founding editorial board member of The Lancet Neurology. Has led national and international projects funded by the European Commission\, IMI\, the Alzheimer’s Association\, Italian and Swiss Ministry of Health\, and industry. Chairman of Alzheimer’s Imaging Consortium at International Conference on Alzheimer’s Disease in 2010 and 2011. Honorary member of the Austrian Neurological Society and of the French Society of Neurology\, he has received the Investigator Award Winner of European Academy of Neurology in 2016.
URL:https://www.braincouncil.eu/event/diagnosis-diagnostic-tools-cognitive-assessments/
LOCATION:Krakow\, Poland
END:VEVENT
END:VCALENDAR